Aspen Neuroscience Inc. (ASPE:NASDAQ) closed at $12.42 on November 20, 2026, up 0.24% on the day. The stock trades 16.6% below its 52-week high of $14.90 and 10.9% above its 52-week low of $11.20. Over the past year, it lost 16.6%. Aspen Neuroscience Inc. is part of the Health Care sector.
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases with high unmet medical need.
Find more stocks like ASPE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.